Anti-Cancer Treatment Strategies in the Older Population: Time to Test More?
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-Cancer Treatment Strategies in the Older Population: Time to Test More?
Authors
Keywords
-
Journal
GERIATRICS
Volume 6, Issue 2, Pages 42
Publisher
MDPI AG
Online
2021-04-16
DOI
10.3390/geriatrics6020042
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update
- (2020) Nasser H. Hanna et al. JOURNAL OF CLINICAL ONCOLOGY
- The Anticancer Efficacy of Immune Checkpoint Inhibitors According to Patients’ Age
- (2020) Chiara Ciccarese et al. JOURNAL OF IMMUNOTHERAPY
- Management of chemotherapy-induced neutropenia in patients with cancer: 2019 guidelines of the Italian Medical Oncology Association (AIOM)
- (2020) Antonino C. Tralongo et al. TUMORI
- Modulation of temozolomide dose differentially affects T-cell response to immune checkpoint inhibition
- (2019) Aida Karachi et al. NEURO-ONCOLOGY
- The performance of three oncogeriatric screening tools - G8, optimised G8 and CARG - in predicting chemotherapy-related toxicity in older patients with cancer. A prospective clinical study
- (2019) David Kotzerke et al. Journal of Geriatric Oncology
- Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study
- (2019) Caroline Robert et al. LANCET ONCOLOGY
- Cancer statistics for adults aged 85 years and older, 2019
- (2019) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
- (2018) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of PD-1 & PD-L1 inhibitors in older adults: a meta-analysis
- (2018) Rawad Elias et al. Journal for ImmunoTherapy of Cancer
- Rationale for the use of metronomic chemotherapy in gastrointestinal cancer
- (2018) Roberto Filippi et al. EXPERT OPINION ON PHARMACOTHERAPY
- Predicting chemotherapy toxicity in older adults: Comparing the predictive value of the CARG Toxicity Score with oncologists' estimates of toxicity based on clinical judgement
- (2018) Erin B. Moth et al. Journal of Geriatric Oncology
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Combination of Immune Checkpoint Inhibition with Metronomic Chemotherapy as a Way of Targeting Therapy-Resistant Cancer Cells
- (2017) Irina Kareva INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527
- (2017) Rachel A. Freedman et al. JOURNAL OF CLINICAL ONCOLOGY
- The Biology of Aging and Cancer: A Brief Overview of Shared and Divergent Molecular Hallmarks
- (2017) Jan R. Aunan et al. Aging and Disease
- Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012
- (2016) Herbert H. Pang et al. JOURNAL OF CLINICAL ONCOLOGY
- Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
- (2015) Chih-Hao Chang et al. CELL
- Biology of Cancer and Aging: A Complex Association With Cellular Senescence
- (2014) Claire Falandry et al. JOURNAL OF CLINICAL ONCOLOGY
- A meta-analysis of cognitive impairment following adult cancer chemotherapy.
- (2014) Oana C. Lindner et al. NEUROPSYCHOLOGY
- Influence of cyclophosphamide and its metabolic products on the activity of peritoneal macrophages in mice
- (2014) Krzysztof Bryniarski et al. Pharmacological Reports
- Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study
- (2013) Roberta De Angelis et al. LANCET ONCOLOGY
- Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial
- (2012) Eva Ellebaek et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Ageing as a Risk Factor for Disease
- (2012) Teresa Niccoli et al. CURRENT BIOLOGY
- Hallmarks of human “immunosenescence”: adaptation or dysregulation?
- (2012) Graham Pawelec Immunity & Ageing
- Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score
- (2011) Martine Extermann et al. CANCER
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The PDL1-PD1 Axis Converts Human TH1 Cells into Regulatory T Cells
- (2011) S. Amarnath et al. Science Translational Medicine
- PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
- (2009) Loise M. Francisco et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
- (2009) S. Ostrand-Rosenberg et al. JOURNAL OF IMMUNOLOGY
- Chemomodulation of human dendritic cell function by antineoplastic agents in low noncytotoxic concentrations
- (2009) Ramon Kaneno et al. Journal of Translational Medicine
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now